124 SERUM CARTILAGE OLIGOMERIC MATRIX PROTEIN HYALURONAN HIGH-SENSITIVITY C-REACTIVE PROTEIN AND KERATAN SULFATE AS PREDICTORS OF INCIDENT RADIOGRAPHIC KNEE OSTEOARTHRITIS: DIFFERENCES BY CHRONIC KNEE SYMPTOMS  by Golightly, Y.M. et al.
S62 Poster Presentations / Osteoarthritis and Cartilage 18, Supplement 2 (2010) S45–S256
rated by SDS-PAGE, transferred to PVDF membranes, and probed by FFGV
(BC-14), IPEN and TEGE neoepitope antibodies, and by antibodies against
aggrecan G1 and G3 domains. Immunodetected aggrecan fragments were
quantiﬁed using chemiluminescence and digital luminescence imager. N-
and C-terminal ends not veriﬁed by immunodetection where estimated
using a calculation model.
Results: The Western blot results showed that MMP-3 cleaves aggrecan in
several sites in six separate regions (a–f, Fig. 1). Time dependent kinetic
studies showed that the most preferred MMP cuts in aggrecan were in
region a, e and f. The second most preferred cut occurred in region d,
while cuts in region b and c were the least preferred. Also, in both young
(knee healthy) and adult (OA) cartilage, Western blot quantiﬁcation of the
in vivo MMP-generated G1-IPEN fragment was 3 times lower (mol/mol)
compared to the in vivo aggrecanase generated G1-TEGE fragment. Except
for the common G1-IPEN other fragments were detected in cartilage in vivo
(G1-CS1, 210-245 kDa) and in OA synovial ﬂuid (ARGS-CS1, 130-160 kDa;
CS1-KEEE 125 kDa) with suggested N- and C-terminals from MMP cuts in
the CS1 region.
Figure 1. Several MMP cleavage sites were found in six regions (a–f) in human aggrecan.
OA cartilage (A1D1) was in vitro digested by MMP-3 and fragments were visualized by
Western blot. Illustration of human aggrecan, MMP cleavage sites and MMP-3 in vitro
generated fragments (Mw in kDA).
Conclusions: There are at least 24 potentially MMP cleavage sites in the
CS1 domain but our results suggest that only a few sites, in the beginning
and in the end of this domain, are available for MMP proteolysis. Two of
the MMP cuts, in the IGD and in the KS region, results in loss of most of the
glycosaminoglycans from aggrecan and thereby loss of cartilage resilience.
Quantiﬁcation of in vivo generated G1-IPEN and G1-TEGE fragments indi-
cate signiﬁcant contribution of MMP proteolysis against aggrecan in both
young (knee healthy) and adult (OA) cartilage.
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Purpose: Molecules that are released into biological ﬂuids during matrix
metabolism and/or cellular activity in articular cartilage, subchondral bone,
and synovial tissue could serve as biochemical markers of the process of
osteoarthritis (OA). Unfortunately, actual breakthroughs in the biochemical
OA marker ﬁeld are limited so far. Critical evaluation of knowledge on the
performance of currently available biochemical OA markers could guide
and stimulate further biochemical OA marker research. Therefore, biochem-
ical OA marker performance was systematically reviewed according to the
“BIPED” classiﬁcation, as published in 2006 in O&C.
Methods: PubMed, Scopus and EMBASE were systematically searched for
publications on blood and urinary biochemical markers in human primary
knee and hip OA. 84 relevant publications were identiﬁed. Data were
scored and tabulated according to the “BIPED” classiﬁcation.
Results: 26 biochemical OA markers were scored according to the “BIPED”
classiﬁcation structure. Comparison of individual biochemical marker per-
formance was hampered by an uneven distribution of “BIPED” scores;
uCTX-II and sCOMP were investigated most extensively. Also, studies
showed heterogenic designs. The majority of studies involved relatively
small cohorts and/or a cross-sectional design. Therefore, comparison of
categories of biochemical markers was performed instead. Biochemical
markers of cartilage degradation were investigated most extensively and
performed well in comparison with other categories. Biochemical mark-
ers of bone metabolism performed less adequately. Biochemical markers
of synovial tissue activity were investigated minimally, but performed
relatively well.
Conclusions: This systematic review shows that there is a lack of consis-
tent, high-quality evidence for the vast majority of commercially available
biochemical OA markers. This lack of interest for some of the markers is not
necessarily supported by publications showing their limited applicability.
Additional investigation of biochemical OA markers in large-scale and/or
longitudinal cohort studies is crucial to increase our knowledge on the
applicability of these markers. Importantly, also the nature, origin and
metabolism of biochemical markers need further investigation. Interna-
tional standardization of such future investigations should be pursued
to obtain more high-quality, homogenous data on the full spectrum of
biochemical markers. Finally, all involved parties should realize that most
biochemical markers are still in an explorative stage and publication bias is
therefore undesirable and should be prevented.
This study was funded by CHECK (Cohort Hip & Cohort Knee), an initiative
of the Dutch Arthritis Association.
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Purpose: To explore prognostication of incident radiographic osteoarthritis
(OA) at the knee with OA-related biomarkers: cartilage oligomeric ma-
trix protein (COMP), hyaluronan (HA), high-sensitivity C-reactive protein
(hsCRP), and keratan sulfate (KS) in a large, community-based sample.
Methods: Baseline serum biomarkers of COMP,and KS were measured
using in-house sandwich enzyme linked immunosorbent assays, HA was
measured with the Hylauronic Acid Test kit, and hsCRP was measured with
the UBI Magiwel Enzyme Immunoassay for 803 participants recruited from
1991-1997 in the Johnston County Osteoarthritis Project. Follow-up assess-
ments were completed from 1999-2003 (mean = 6.3 years; range= 3.0 - 10.2
years). Linked baseline and follow-up anterior-posterior radiographs with
weight-bearing and footmat positioning were read for Kellgren-Lawrence
(KL) grade (0-4) and osteophyte (OST) and joint space narrowing (JSN;
both 0-3 with Burnett atlas). Three incident radiographic OA outcomes
were explored and deﬁned as: 1) a KL grade of 0-1 at baseline and ≥2 at
follow-up, 2) an OST grade=0 at baseline and ≥1 at follow-up, and 3) a
JSN grade=0 at baseline and ≥1 at follow-up. Five hundred forty two knees
were at risk for incident OA by KL grades (KL grade of 0-1 at baseline),
349 knees at risk for incident OST formation (OST=0 at baseline), and
440 knees at risk for incident JSN (JSN=0 at baseline). For each outcome,
Cox regression models were used to estimate the hazard ratio (HR) for
a 1-unit increase in the natural log of each biomarker, adjusting for age,
race, gender, and body mass index and accounting for bilateral clustering
of knees using robust variance estimates. History of lower extremity injury
(knee or hip injury or fracture) and chronic knee symptoms were explored
as potential modiﬁers of the association.
Results: In adjusted models, the hazard of incident knee OA by KL and
OST increased with higher baseline lnCOMP levels (adjusted HR [aHR]
= 1.46, 95% conﬁdence interval [CI] = 0.96-2.23, and aHR= 2.26, 95% CI
=1.45-3.53, respectively). The hazard of incident knee JSN also increased
with higher lnCOMP levels (aHR=2.14, 95% CI= 1.32-3.47) and higher lnHA
levels (aHR=1.63, 95% CI= 1.26-2.12). In unstratiﬁed analyses, higher levels
of lnhsCRP and lnKS did not predict the incident knee outcomes. Neither
history of lower extremity injury nor chronic knee symptoms was a strong
modiﬁer of these associations (p > 0.10). However, a pattern was observed
of higher adjusted HRs for lnCOMP, lnHA, and, most notably, for lnKS with
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Abstract 124 – Table 1. Adjusted Hazard Ratios (HR) of Knee Outcomes, by Biomarker, Stratiﬁed by Chronic Knee Symptoms
Biomarker Knee Outcome Chronic Knee Symptoms No Chronic Knee Symptoms P-value of interaction between
between ln(biomarker) and knee symptoms# Knees # Knees Adjusted HR 95% CI # Knees # Knees Adjusted HR 95% CI
at Risk with Outcome at Risk with Outcome
ln(COMP) KL Score 166 46 1.49 0.80-2.78 374 64 1.43 0.80-2.54 0.83
OST 97 33 4.19 1.85-9.48 250 61 1.83 1.02-3.30 0.11
JSN 129 35 2.47 1.08-5.65 308 64 1.98 1.07-3.66 0.46
ln(HA) KL Score 166 46 1.30 0.91-1.87 374 64 1.02 0.77-1.35 0.81
OST 97 33 1.13 0.67-1.89 250 61 0.86 0.63-1.17 0.29
JSN 129 35 2.12 1.37-3.28 308 64 1.47 1.08-2.00 0.22
ln(hsCRP) KL Score 166 46 0.98 0.76-1.27 374 64 1.00 0.80-1.24 0.67
OST 97 33 1.03 0.75-1.41 250 61 0.88 0.71-1.10 0.23
JSN 129 35 1.08 0.78-1.49 308 64 1.10 0.90-1.36 0.13
ln(KS) KL Score 166 46 1.79 0.74-4.32 374 64 0.91 0.43-1.95 0.12
OST 97 33 3.85 1.25-11.87 250 61 1.19 0.52-2.71 0.42
JSN 129 35 2.78 0.98-7.90 308 64 0.86 0.41-1.83 0.24
OST and JSN outcomes among knees with chronic symptoms at baseline
compared to knees without symptoms.
Conclusions: Higher baseline lnCOMP and lnHA levels were associated
with incident knee OA, OST, and JSN over an average follow-up period of
6.3 years. These results did not vary by history of lower extremity injury,
but this interpretation is incomplete due to power limitations and the po-
tential misclassiﬁcation that comes with self-report and long duration since
reported injury. The presence of chronic knee symptoms, in combination
with higher levels of serum COMP, HA, or KS, may provide clues to the
early detection of OA.
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HYPOCHLOROUS ACID IN OSTEOARTHRITIC CARTILAGE AND SYNOVIAL
FLUID - AN EX-VIVO HRMAS STUDY
K. Shet, J. Kurhanewicz, M. Ries, X. Li
Univ. of California, San Franscisco, San Francisco, CA
Purpose: Proteoglycan degradation and alteration in the cartilage has been
considered an important marker for detecting and measuring the progress
of OA. Hypoxic conditions, reactive oxygen species (ROS) and an elevation
in the activities of proteolytic enzymes (aggrecanases) are considered
as potential factors that cause this degradation. Recent evidence shows
that myeloperoxidase mRNA increased in OA. Myeloperoxidase catalyses
the formation of hypochlorous acid (HOCl). HOCL is a ROS and causes
a breakdown of the glycosidic linkage in the cartilage polymers namely
N-acetyl-glucosamine, thereby making the N-Ac groups more mobile and
this results in an enhancement of the N-Ac resonance in OA cartilage.
Acetate is a ﬁnal by-product of the degradation of N-Acetyl side chains in
the polysaccharides of cartilage brought about by HOCl. With increasing
HOCl activity in OA there is an increase in the acetate resonance. The aim of
this study was to analyse cartilage and synovial ﬂuid samples from severe
OA patients using high resolution magic angle spinning NMR spectroscopy
at 11.7 T to detect the presence of hypochlorous activity in OA.
Methods: Six OA cartilage samples and synovial ﬂuid specimens were
harvested from 6 patients who underwent Total Knee Arthroplasty (TKA)
surgeries; Cartilage samples were acquired using 3.5 mm biopsy punches
from the lateral inferior femoral condyle. The samples were ﬂash frozen at
-80°C for storage. The samples were scanned in a 500MHz Varian INOVA
spectrometer in a 30μL zirconium rotor which was spun at a rate of 2.25
kHz. The reference used was 0.75 mass % 3-(trimethylsilyl) propionic-2, 2,
3, 3-d4 acid (TSP in D2O). The 1-D HR-MAS NMR spectra were acquired at a
temperature of 1°C. 1-D Carr-Purcell-Meiboom-Gill (CPMG) sequence that
was rotor synchronized (i.e., τ delay = n x (spin rate)-1, where n is an even
number) with an echo-time of 44 ms for cartilage and 60 ms for synovial
ﬂuid was acquired for each sample. A spectral bandwidth of 20 kHz was
used in the above experiment. The CPMG acquisition was preceded by a
2-sec water pre-saturation pulse to minimize the water signal at 5 ppm
and to ensure a ﬂat baseline. The NMR spectra were processed using the
ACD Labs 1D NMR processor (ver. 8.0). The 1D FID’s were apodized with
an exponential function, Fourier transformed, phase-corrected, baseline
corrected and referenced to TSP at 0 ppm.
Results: Figure 1 (a) and (b) show the Carr-Purcell Meiboom Gill (CPMG)
spectra of cartilage and synovial ﬂuid drawn from a severe OA patient.
The metabolites in the spectra that may relate to free radical effect on
cartilage are the N-Acetyl (N-Ac) resonance and acetate (A). The N-Ac peak
at 2.04 ppm is known to arise from the glycoproteins. Free radicals cause
a breakdown of the glycosidic linkage, resulting in an enhancement of
the N-Ac resonance in OA cartilage. Acetate is a ﬁnal by-product of the
degradation of N-Acetyl side chains. With increasing HOCl activity in OA
there is an increase in the acetate resonance at 1.92 ppm. The N-Ac and
acetate resonance are sharper in case of synovial ﬂuid.
Conclusions: An enhancement of the N-acetyl resonance in both the
cartilage and synovial ﬂuid spectra could be attributed to degradation in
OA. This degradation may be due ROS activity. The detection of acetate in
OA specimens in both cartilage and synovial ﬂuid specimens is evidence
of HOCL activity in OA. It is also important to note that the detection of
acetate in synovial ﬂuid indicates the fact that there is a movement of
HOCL and products of HOCL degradation from cartilage to the synovial
space. This information is vital in the design of anti-oxidant therapy to
reduce ROS damage and to treat rheumatic disease.
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Purpose: Change in cartilage thickness is assumed to be localized and
